Article Sidebar

Submitted
20 April 2024
Accepted
22 June 2024
Published
10 June 2024
Download
PDF
Statistic
Read Counter : 27 Download : 18

Main Article Content

Abstract

Highlights:
1. This study compared the serological markers of pristane-induced mice to humanized mouse models of lupus achieved by transplanting stem cells from lupus patients, which is a novel method in Indonesia.
2. This study will allow for more accurate research into the pathophysiology of the disease and the development of new lupus treatment strategies.


 


Abstract


More studies related to systemic lupus erythematosus (SLE) therapy are urgently needed because of the current insufficiency in treatment effectiveness. However, due to ethical limitations, researchers use experimental animals as a substitute for conducting studies on humans. Models commonly used to study lupus include the pristane-induced mouse model and the recently developed humanized mouse model. The second model involves implanting human immune cells into immunodeficient mice. This study compared the serologic profiles of lupus antibodies, the antinuclear antibodies (ANA) and anti-double stranded DNA (anti-dsDNA), in both mouse models. The aim was to determine which one is more promising for use as a lupus animal model. Thirty BALB/c mice (Mus musculus) were used as subjects and divided into three groups: K1, K2, and K3. K1 served as the control group, consisting of healthy mice that received a placebo. The K2 mice were intraperitoneally injected with 0.5 cc of pristane. The K3 mice were transplanted with stem cell cultures from SLE patients, resulting in humanized mice with immune deficiencies. The mice were observed for 16 weeks, during which the ANA and anti-dsDNA levels in their serum were obtained for analysis using the Kruskal-Wallis test (p<0.05). The comparison revealed differences in the average ANA and anti-dsDNA levels among the three groups. K3 had the highest ANA and anti-dsDNA levels, followed by K1 and K2. The Kruskal-Wallis test indicated that the differences were not significant in the mean levels of ANA (p=0.156) and anti-dsDNA (p=0.061). In conclusion, the humanized mouse model has higher ANA and anti-dsDNA antibody levels compared to the pristane-induced mouse model, albeit without a significant difference. This suggests a positive picture of the humanized mouse model of lupus, making it an invaluable tool for studying the disease and testing potential therapeutic interventions.


 

Keywords

systemic lupus erythematosus humanized mice model of lupus pristane induced lupus disease

Article Details

License

Copyright (c) 2024 Folia Medica Indonesiana

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

  • Folia Medica Indonesiana is a scientific peer-reviewed article which freely available to be accessed, downloaded, and used for research purposes. Folia Medica Indonesiana (p-ISSN: 2541-1012; e-ISSN: 2528-2018) is licensed under a Creative Commons Attribution 4.0 International License. Manuscripts submitted to Folia Medica Indonesiana are published under the terms of the Creative Commons License. The terms of the license are:

    Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

    NonCommercial ” You may not use the material for commercial purposes.

    ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.

    No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

    You  are free to :

    Share ” copy and redistribute the material in any medium or format.

    Adapt ” remix, transform, and build upon the material.

How to Cite
Syahrul Chilmi, Dimas Ikhsan Airlangga, Hani Susianti, & Kusworini Handono. (2024). Serological Profiles of Systemic Lupus Erythematosus in Humanized Mice and Pristane-Induced Lupus Models. Folia Medica Indonesiana, 60(2), 134–140. https://doi.org/10.20473/fmi.v60i2.56828
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Adigbli G, Ménoret S, Cross AR, et al (2020). Humanization of immunodeficient animals for the modeling of transplantation, graft versus host disease, and regenerative medicine. Transplantation 104, 2290–2306. doi: 10.1097/TP. 0000000000003177.
  2. Cai YH, Deng J, Chen ZL, et al (2022). Brief report on the relation between complement C3a and anti dsDNA antibody in systemic lupus erythematosus. Scientific Reports 12, 7098. doi: 10.1038/s41598-022-10936-z.
  3. Chen J, Liao S, Zhou H, et al (2022). Humanized mouse models of systemic lupus erythematosus: Opportunities and challenges. Frontiers in Immunology. doi: 10.3389/fimmu.2021.816956.
  4. Cleophas TJ, Zwinderman AH (2016). Non-parametric tests for three or more samples (Friedman and Kruskal-Wallis). In Clinical Data Analysis on a Pocket Calculator, 193–197. Springer International Publishing, Cham. Available at: http://link.springer.com/10.1007/978 -3-319-27104-0_34.
  5. da Costa TA, Lang J, Torres RM, et al (2019). The development of human immune system mice and their use to study tolerance and autoimmunity. Journal of Translational Autoimmunity 2, 100021. doi: 10.1016/j.jtauto.2019.100021.
  6. Freitas EC, de Oliveira MS, Monticielo OA (2017). Pristane-induced lupus: Considerations on this experimental model. Clinical Rheumatology 36, 2403–2414. doi: 10.1007/s10067-017-3811-6.
  7. González DA, Varela AR, Rodríguez IM, et al (2015). Anti-dsDNA antibodies in systemic lupus erythematosus: A combination of two quantitative methods and the ANA pattern is the most efficient strategy of detection. Journal of Immunological Methods 427, 30–35. doi: 10.1016/j.jim.2015. 09.003.
  8. Gridley T, Murray SA (2022). Mouse mutagenesis and phenotyping to generate models of development and disease, 1–12. Available at: https://linkinghub.elsevier.com/retrieve/pii/S0070215322000291.
  9. Grigoriou M, Banos A, Filia A, et al (2020). Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosus. Annals of the Rheumatic Diseases 79, 242–253. doi: 10.1136/annrheumdis-2019-215782.
  10. Gunawan M, Her Z, Liu M, et al (2017). A novel human systemic lupus erythematosus model in humanised mice. Scientific Reports 7, 16642. doi: 10.1038/s41598-017-16999-7.
  11. IBM Corp. (2016). IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY: IBM Corp. Available at: https://www.ibm.com/support/pages /downloading-ibm-spss-statistics-24.
  12. Jang A, Sharp R, Wang JM, et al (2021). Dependence on autophagy for autoreactive memory B cells in the development of pristane-induced lupus. Frontiers in Immunology. doi: 10.3389/fimmu.2021.701066.
  13. Justice MJ, Dhillon P (2016). Using the mouse to model human disease: Increasing validity and reproducibility. Disease Models & Mechanisms 9, 101–103. doi: 10.1242/dmm.024547.
  14. Justiz Vaillant AA, Goyal A, Varacallo M (2024). Systemic lupus erythematosus. Available at: http://www.ncbi.nlm.nih.gov/pubmed/35246682.
  15. Lee JY, Hong SH (2020). Hematopoietic stem cells and their roles in tissue regeneration. International Journal of Stem Cells 13, 1–12. doi: 10.15283/ijsc19127.
  16. Li W, Titov AA, Morel L (2017). An update on lupus animal models. Current Opinion in Rheumatology 29, 434–441. doi: 10.1097/BOR. 0000000000000412.
  17. Mian SA, Anjos-Afonso F, Bonnet D (2021). Advances in human immune system mouse models for studying human hematopoiesis and cancer immunotherapy. Frontiers in Immunology. doi: 10.3389/fimmu.2020.619236.
  18. Mihaylova N, Chipinski P, Bradyanova S, et al (2020). Suppression of autoreactive T and B lymphocytes by anti-annexin A1 antibody in a humanized NSG murine model of systemic lupus erythematosus. Clinical and Experimental Immunology 199, 278–293. doi: 10.1111/cei. 13399.
  19. Ocampo-Piraquive V, Nieto-Aristizábal I, Cañas CA, et al (2018). Mortality in systemic lupus erythematosus: Causes, predictors and interventions. Expert Review of Clinical Immunology 14, 1043–1053. doi: 10.1080/1744666X.2018.1538789.
  20. Pan N, Amigues I, Lyman S, et al (2014). A surge in anti-dsDNA titer predicts a severe lupus flare within six months. Lupus 23, 293–298. doi: 10.1177/0961203313515763.
  21. Pisetsky DS, Lipsky PE (2020). New insights into the role of antinuclear antibodies in systemic lupus erythematosus. Nature Reviews Rheumatology l 16, 565–579. doi: 10.1038/s41584-020-0480-7.
  22. Pittenger MF, Discher DE, Péault BM, et al (2019). Mesenchymal stem cell perspective: Cell biology to clinical progress. npj Regenerative Medicine 4, 22. doi: 10.1038/s41536-019-0083-6.
  23. Rekvig OP (2014). Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: Critical remarks. Clinical and Experimental Immunology 179, 5–10. doi: 10.1111/cei.12296.
  24. Richard ML, Gilkeson G (2018). Mouse models of lupus: What they tell us and what they don’t. Lupus Science & Medicine 5, e000199. doi: 10.1136/lupus-2016-000199.
  25. Scheen M, Adedjouma A, Esteve E, et al (2022). Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management. Autoimmunity Reviews 21, 103072. doi: 10.1016/j.autrev.2022.103072.
  26. Tang WY, Liu JH, Peng CJ, et al (2021). Functional characteristics and application of mesenchymal stem cells in systemic lupus erythematosus. Archivum Immunologiae et Therapiae Experimentalis 69, 7. doi: 10.1007/s00005-021-00603-y.
  27. Tayem MG, Shahin L, Shook J, et al (2022). A review of cardiac manifestations in patients with systemic lupus erythematosus and antiphospholipid syndrome with focus on endocarditis. Cureus. doi: 10.7759/cureus.21698.
  28. Tejon G, Hidalgo Y, Rosa Bono M, et al (2020). A spontaneous mouse model of lupus: Physiology and therapy. In Lupus - New Advances and Challenges. IntechOpen. Available at: https://www.intechopen.com/books/lupus-new-advances-and-challenges/a-spontaneous-mouse-model-of-lupus-physiology-and-therapy.
  29. Tu W, Zheng J (2016). Application of humanized mice in immunological research. In, pp. 157–76. Available at: http://link.springer.com/10.1007/978 -1-4939-3139-2_10.
  30. Wang Q, Qian S, Li J, et al (2015). Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia. Lupus 24, 1221–1226. doi: 10.1177/0961203315583541.
  31. Zschaler J, Schlorke D, Arnhold J (2014). Differences in innate immune response between man and mouse. Critical reviews in immunology 34, 433–454. doi: 25404048.